We are live on ! Find out more
KURA icon

Kura Oncology
KURA

119 hedge funds and large institutions have $421M invested in Kura Oncology in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 41

7.27% more ownership

Funds ownership: 86.16% → 93.43% (+7.3%)

6% less funds holding

Funds holding: 127 → 119 (-8)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

22% less capital invested

Capital invested by funds: $537M → $421M (-$116M)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

76% less call options, than puts

Call options by funds: $35K | Put options by funds: $147K

Holders
119
Holders Change
-8
Holders Change %
-6.3%
% of All Funds
2.62%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
13
Increased
47
Reduced
41
Closed
19
Calls
$35K
Puts
$147K
Net Calls
-$112K
Net Calls Change
-$189K

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$32.6M
2
IC
Ikarian Capital
Texas
+$8.7M
3
Citadel Advisors
Citadel Advisors
Florida
+$6.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.72M
5
BI
BVF Inc
California
+$5M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.36M
2
GPP
Great Point Partners
Connecticut
-$7.72M
3
Goldman Sachs
Goldman Sachs
New York
-$6.38M
4
ORI
Oak Ridge Investments
Illinois
-$2.88M
5
CAM
Cormorant Asset Management
Massachusetts
-$2.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
DAFNA Capital Management
California
$3.06M +$1.53M +134,066 +77%
Charles Schwab
27
Charles Schwab
California
$2.51M +$22.8K +1,993 +0.8%
Aviva
28
Aviva
United Kingdom
$2.47M +$2.85M +248,589 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$2.41M +$1.23M +107,500 +80%
WCM Investment Management
30
WCM Investment Management
California
$2.33M +$776K +67,786 +41%
ACP
31
Acuta Capital Partners
California
$1.97M -$481K -42,000 -18%
GPP
32
Great Point Partners
Connecticut
$1.79M -$7.72M -674,077 -79%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.73M -$1.02M -89,380 -34%
Two Sigma Investments
34
Two Sigma Investments
New York
$1.65M -$168K -14,653 -8%
EAM
35
Erste Asset Management
Austria
$1.61M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.49M +$56.3K +4,919 +3%
CIA
37
Capital Impact Advisors
Massachusetts
$1.4M +$95.7K +8,361 +6%
AGA
38
Altrinsic Global Advisors
Connecticut
$1.09M +$229K +20,000 +22%
KCM
39
Kennedy Capital Management
Missouri
$1.05M -$50.2K -4,383 -4%
CAM
40
ClariVest Asset Management
California
$1.03M +$66.9K +5,843 +6%
PC
41
PA Capital
Virginia
$998K +$415K +36,270 +57%
Goldman Sachs
42
Goldman Sachs
New York
$960K -$6.38M -557,411 -85%
FCMI
43
Foresite Capital Management IV
California
$925K +$286K +25,000 +37%
Squarepoint
44
Squarepoint
New York
$911K -$431K -37,646 -29%
BFM
45
Boothbay Fund Management
New York
$854K +$983K +85,849 New
Renaissance Technologies
46
Renaissance Technologies
New York
$848K +$976K +85,271 New
Bank of America
47
Bank of America
North Carolina
$821K -$14.7K -1,284 -2%
AA
48
ALPS Advisors
Colorado
$820K -$110K -9,601 -10%
AG
49
Algert Global
California
$813K +$604K +52,800 +183%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$761K +$37.8K +3,300 +5%
1
2
3 4 5

KURA Hedge Fund Activity: Q1 2020 in Review

119 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2020, worth a combined $421M — down 22% from $537M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of KURA and 13 opened new positions — a net loss of 6 holders — while 41 trimmed existing stakes and 47 added.

The largest buyer was Victory Capital Management, adding an estimated $32.6M. The largest seller was EcoR1 Capital, cutting an estimated $8.36M.

  • 119 institutional investors held Kura Oncology (KURA) as of Q1 2020, down from 127 in Q4 2019.
  • Funds reported $421M of Kura Oncology stock for Q1 2020, down 22% quarter-over-quarter.
  • 13 funds opened new Kura Oncology positions in Q1 2020 and 19 closed out, a net change of -6 holders.
  • The largest Kura Oncology buyer in Q1 2020 was Victory Capital Management, an estimated $32.6M added.
  • The largest Kura Oncology seller in Q1 2020 was EcoR1 Capital, an estimated $8.36M sold.

Based on aggregated 13F filings for Q1 2020.